What is the recommended anesthesia plan for a 43-year-old female (F), weighing 61.2kg, with a history of occasional (occ) migraines, classified as American Society of Anesthesiologists (ASA) 1, undergoing a vaginal hysterectomy using spinal anesthesia with sedation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Anesthesia Plan for Vaginal Hysterectomy with Spinal and Sedation

For this 43-year-old, 61.2kg, ASA 1 patient undergoing vaginal hysterectomy, administer 12 mg (1.6 mL) of 0.5% hyperbaric bupivacaine intrathecally using a pencil-point spinal needle, followed by propofol sedation at 0.4 mg/kg loading dose then 1.5-2 mg/kg/hr infusion to maintain conscious sedation. 1

Preoperative Preparation

  • NPO Status: Clear liquids permitted up to 2 hours before procedure; solid foods avoided for 6-8 hours 2
  • Aspiration Prophylaxis: Administer nonparticulate antacid (e.g., sodium citrate 30 mL), consider adding ranitidine 50 mg IV and/or metoclopramide 10 mg IV within 60 minutes of procedure start 2
  • Antibiotic Prophylaxis: Cefazolin 2g IV (or 3g if >120kg) within 60 minutes before incision 3
  • IV Access: Establish 18-gauge or larger IV catheter before initiating spinal anesthesia 1
  • Preemptive Analgesia: Consider acetaminophen 1000 mg PO and/or celecoxib 200-400 mg PO 1-2 hours preoperatively 2, 3

Spinal Anesthesia Technique

Dosing: Use 12 mg (1.6 mL) of 0.5% hyperbaric bupivacaine in dextrose for lower abdominal procedures including vaginal hysterectomy 1. This dose provides adequate sensory level (T10) and duration (2-3 hours) for the procedure 4, 5.

Needle Selection: Use pencil-point spinal needle (Whitacre or Sprotte, 25-27 gauge) instead of cutting-bevel needle to minimize post-dural puncture headache risk 2

Positioning: Perform spinal in sitting position for optimal distribution of hyperbaric solution 4

Technique:

  • Position patient sitting with back flexed
  • Identify L3-4 or L4-5 interspace
  • Aspirate to confirm CSF flow and observe characteristic "swirl" when bupivacaine mixes with CSF 1
  • Inject slowly over 15-30 seconds
  • Position patient supine immediately after injection

Sedation Protocol

Propofol Conscious Sedation: This is the preferred sedation technique for vaginal hysterectomy under spinal anesthesia 6

  • Loading Dose: 0.2-0.4 mg/kg (12-24 mg for this 61.2kg patient) administered in 0.2 mg/kg increments every minute until spontaneous eye closure or nystagmus appears 6
  • Maintenance Infusion: 1.5-2 mg/kg/hr (92-122 mg/hr or approximately 25-35 mcg/kg/min) adjusted to maintain conscious sedation with spontaneous ventilation 6
  • Titration Goal: Patient should respond to verbal stimulation but remain comfortable and amnestic 2, 6

Alternative Sedation: If propofol unavailable, use midazolam 1-2 mg IV boluses titrated to effect, though propofol provides superior respiratory profile 6

Intraoperative Monitoring and Management

Standard Monitoring: Continuous pulse oximetry, ECG, non-invasive blood pressure every 3-5 minutes initially then every 5-15 minutes, capnography if sedation depth increases 2

Hypotension Management:

  • Expect sympathetic blockade causing vasodilation 1
  • Treat MAP <65 mmHg lasting >5 minutes with phenylephrine 50-100 mcg IV boluses or ephedrine 5-10 mg IV 5
  • Maintain IV crystalloid at 500-1000 mL during procedure for euvolemic state 3

Respiratory Monitoring: Propofol sedation at these doses actually improves respiratory parameters compared to no sedation during spinal anesthesia 6. Monitor respiratory rate, SpO2 >95%, and nasal ETCO2 <50 mmHg 2, 6

Supplemental Oxygen: Provide 2-4 L/min via nasal cannula 2

Postoperative Analgesia

Multimodal Approach:

  • Scheduled acetaminophen 1000 mg PO/IV every 6 hours 2, 3
  • Scheduled NSAID: ketorolac 15-30 mg IV every 6 hours (maximum 5 days) or ibuprofen 600 mg PO every 6 hours 2
  • Opioid rescue only: oxycodone 5 mg PO every 4 hours PRN for breakthrough pain (NRS >4) 2, 5

Expected Pain Control: Spinal bupivacaine provides excellent analgesia for 4-8 hours postoperatively, with significantly lower pain scores and reduced opioid requirements compared to general anesthesia alone 5, 7

Critical Safety Considerations

Avoid These Pitfalls:

  • Do NOT inject spinal during uterine contractions if patient in labor (not applicable here but critical safety point) 1
  • Do NOT use cutting-bevel spinal needles due to increased PDPH risk 2
  • Do NOT allow propofol sedation to progress to deep sedation/general anesthesia—maintain verbal responsiveness 2
  • Do NOT administer additional local anesthetic doses without considering cumulative toxicity risk 1

Emergency Preparedness: Have lipid emulsion 20% immediately available for local anesthetic systemic toxicity (LAST), though risk is minimal with proper spinal technique 1. Ensure resuscitation equipment and vasopressors at bedside 2, 1.

Migraine Consideration: Her history of occasional migraines is not a contraindication to spinal anesthesia. Ensure adequate hydration and consider ondansetron 4 mg IV for PONV prophylaxis, as nausea can trigger migraines 2.

Recovery and Discharge

Recovery Room Monitoring: Continue monitoring until sensory level regresses to L2-L3, motor function returns (Bromage score ≤2), and hemodynamics stable 5

Expected Recovery Time: Patients receiving spinal with propofol sedation meet discharge criteria approximately 90-100 minutes postoperatively, faster than general anesthesia alone 5

Mobilization: Ambulate once motor block resolved (typically 3-4 hours) and orthostatic vital signs stable 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.